Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Roivant Sciences Ltd. Director's Dealing 2023

Feb 22, 2023

30587_dirs_2023-02-22_42b11f6f-5f42-49c6-a86b-0d468dda2e59.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Roivant Sciences Ltd. (ROIV)
CIK: 0001635088
Period of Report: 2023-02-22

Reporting Person: Ramaswamy Vivek (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-02-22 Common Shares S 4000000 $7.95 Disposed 54409211 Direct

Footnotes

F1: The reporting person does not expect to sell additional shares of the Issuer for the foreseeable future.

F2: Reflects an award of restricted stock covering Common Shares that is fully vested.